Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancer.
- DOI
- 10.1038/s41598-026-35423-7
- Published
- 2026 Jan 31
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-026-35423-7,
title = {Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancer.},
author = {McVey JC and Wattenberg MM and Coho H and Infante K and Markowitz K and Delman D and Clendenin C and Furth EE and Tondon R and Stanger BZ and Vonderheide RH and Reiss KA and Beatty GL},
year = {2026},
journal = {Scientific reports},
doi = {10.1038/s41598-026-35423-7},
url = {https://doi.org/10.1038/s41598-026-35423-7}
}RIS
TY - JOUR TI - Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancer. AU - McVey JC AU - Wattenberg MM AU - Coho H AU - Infante K AU - Markowitz K AU - Delman D AU - Clendenin C AU - Furth EE AU - Tondon R AU - Stanger BZ AU - Vonderheide RH AU - Reiss KA AU - Beatty GL PY - 2026 JO - Scientific reports DO - 10.1038/s41598-026-35423-7 UR - https://doi.org/10.1038/s41598-026-35423-7 ER -
APA
JC, M., MM, W., H, C., K, I., K, M., D, D., C, C., EE, F., R, T., BZ, S., RH, V., KA, R., & GL, B. (2026). Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancer.. Scientific reports. https://doi.org/10.1038/s41598-026-35423-7
Source records
- pubmed · retrieved 2026-09-25T17:34:08.319Z